Anna F. Lau

4.1k citations
52 papers · 2.0k indexed · h-index 26

Anna F. Lau

48 papers receiving 1.9k citations

Peers

Anna F. Lau
Comparison fields: 5 of 128
  • Molecular Medicine 426
  • Clinical Biochemistry 461
  • Endocrinology 242
  • Infectious Diseases 723
  • Applied Microbiology and Biotechnology 78
Replace Noura Al‐Sweih with:
Noura Al‐Sweih Kuwait
Shigefumi Maesaki Japan
Yoshitomo Morinaga Japan
Audrey N. Schuetz United States
Charalampos Antachopoulos Greece
Teresa Fasciana Italy
Domenico D’Antonio Italy
G. Marklein Germany
Jong Hee Shin South Korea
Frédéric Dalle France
Anna F. Lau relative to Noura Al‐Sweih Kuwait Noura Al‐Sweih's profile →
Citations per field
00.5×3.5×
Noura Al‐Sweih · 1×
Citations per year

Countries citing papers authored by Anna F. Lau

Since Specialization
Citations

This map shows the geographic impact of Anna F. Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna F. Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna F. Lau more than expected).

Fields of papers citing papers by Anna F. Lau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna F. Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna F. Lau. The network helps show where Anna F. Lau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anna F. Lau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna F. Lau Line = papers co-authored together Anna F. Lau links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20235
4 20231
5 202127
6 202046
7 201914
8 2018141
9 201841
10 201817
11 201721
12 201635
13 201554
14 201320
15 20122
16 201170
17 200945
18
Multiplex-tandem PCR (MT-PCR) for Rapid Diagnosis of Fungemia
20081
19 2006244
20 200071

About Anna F. Lau

Anna F. Lau is a scholar working on Molecular Medicine, Endocrinology and Clinical Biochemistry, having authored 52 papers that have together received 2.0k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (13 papers), Antifungal resistance and susceptibility (11 papers), Antibiotic Resistance in Bacteria (11 papers), Fungal Infections and Studies (9 papers), Plant Pathogens and Fungal Diseases (9 papers), Vibrio bacteria research studies (6 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). The work is most often cited by research in Molecular Medicine (426 citations), Clinical Biochemistry (461 citations) and Endocrinology (242 citations). Anna F. Lau has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Tania C. Sorrell, John P. Dekker, Catriona Halliday, Karen M. Frank, Sharon Chen, Steven K. Drake, Richard Malík, Dee Carter, Adrian M. Zelazny and Patricia Martín. Their work appears in journals such as New England Journal of Medicine, Genes & Development and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026